Teishima, Jun, et al. “Therapeutic Outcome of Combination Therapy Using Immune-Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Metastatic Non-Clear-Cell Renal Cell Carcinoma ”. Canadian Urological Association Journal, vol. 18, no. 5, Jan. 2024, pp. E162-6, doi:10.5489/cuaj.8548.